Abstract
The process of risk assessment and risk management is widely recognized in the United States as a tool for making policy decisions to control risk associated with toxic chemical exposures. This two-step process, first to evaluate risk and then to decide what, if anything, should be done to reduce exposures, was adopted by the U.S. Environmental Protection Agency (EPA) in 1976 its announcement of guidelines for assessing cancer risk (EPA 1976, Albert et al. 1977). This approach was later endorsed by committees of the National Academy of Sciences (NAS) as the most appropriate process for informed public policy decisions to protect public health from exposure to toxic chemicals (NAS 1982, 1983). Other United States interagency committees reviewed the basis for cancer risk assessment and published background documents that are largely consistent with the earlier and much briefer statement of risk assessment guidance published by EPA in 1976 (IRLG 1979, OSTP 1984). EPA has published updates of its original cancer risk assessment guidelines and guidelines for other health effects that take into account its decade of experience in assessing cancer risks for hundreds of chemicals (EPA 1984a,b,c,d, 1985a, 1986a,b,c,d,e).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albert, R. E., Train, R. E., and Anderson, E. L. 1977. Rationale developed by the Environmental Protection Agency for the assessment of carcinogenic risks. J. Natl. Cancer lnst. 58:1537–1541.
Andersen, M. E., Gargas, M. L., Jones, R. A., and Jenkins, L. J., Jr. 1980. Determination of the kinetic constants for metabolism of inhaled toxicants in vivo using gas uptake measurements. Toxicol. Appl. Pharmacol. 54:100–116.
Andersen, M. E. 1981a. A physiologically based toxicokinetic description of the metabolism of inhaled gases and vapors: Analysis at steady state. Toxicol. Appl. Pharmacol. 60:509–526.
Andersen, M. E. 198lb. Saturable metabolism and its relationship to toxicity. CRC Crit. Rev. Toxicol. 9:105–150.
Andersen, M. E., Gargas, M. L., and Ramsey, J. C. 1984. Inhalation pharmacokinetics: Evaluating systemic extraction, total in vivo metabolism, and the time course of enzyme induction for inhaled styrene in rats based on arterial blood: Inhaled air concentration ratios. Toxicol. Appl. Pharmacol. 73:176–187.
Anderson, E. L., and Carcinogen Assessment Group (CAG) of the Environmental Protection Agency. 1983. Quantitative approaches in use to assess cancer risk. Risk Anal. 3:277–295.
Armitage, P. 1985. Multistage models of carcinogenesis. Environ. Health Perspect. 63:195–201.
Cline, P.V., and D.R. Viste. 1984. Migration and Degradation Patterns of Volatile Organic Compounds. National Conference of Uncontrolled Hazardous Waste Sites Proceedings. P. 217.
Crump, K. S. 1981. Investigation of the Use of Pharmacokinetic Data in Carcinogenic Risk Assessment. (Submitted to Environmental Protection Agency).
Crump, K. S. 1987. Investigation of the Incorporation of Pharmacokinetic Data for Selected Volatile Organic Chemicals into Quantitative Risk Assessment Methodology, (Submitted to State of New Jersey).
Domenico, P.A., and V.V. Palciauskas. 1982. Alternative Boundaries in Solid Waste Management. Groundwater 20:303.
Environmental Protection Agency (EPA). 1976. Interim procedures and guidelines for health risks and economic impact assessments of suspected carcinogens. Fed. Reg. 41:21402.
Environmental Protection Agency (EPA). 1978. Summary and Conclusions for Assessment of Carcinogenic Risk of Chlorobenzilate. Carcinogen Assessment Group (CAG). (Unpublished).
Environmental Protection Agency (EPA). 1979a. Water quality criteria: Request for comments (proposed). Fed. Reg. 44:15926–15981.
Environmental Protection Agency (EPA). 1979b. Water quality criteria: Availability (proposed). Fed. Reg. 44:43660–43697.
Environmental Protection Agency (EPA). 1979c. Water quality criteria: Availability (proposed). Fed. Reg. 44:56628–56656.
Environmental Protection Agency (EPA). 1980. Water quality criteria documents: Availability. Fed. Reg. 45:79316–79379.
Environmental Protection Agency (EPA). 1984a. Proposed guidelines for carcinogen risk assessment. Fed. Reg. 49(227):46294–46301.
Environmental Protection Agency (EPA). 1984b. Proposed guidelines for the health assessment of suspect developmental toxicants. Fed. Reg. 49:46324–46331.
Environmental Protection Agency (EPA). 1984c. Proposed guidelines for mutagenicity risk assessment. Fed. Reg. 49:46312–46321.
Environmental Protection Agency (EPA). 1984d. Proposed guidelines for exposure assessment. Fed. Reg. 49:46304–46312.
Environmental Protection Agency (EPA). 1985. Final Exclusions and Final Vertical and Horizontal Spread Model (VHS). Fed. Reg. 50:229.
Environmental Protection Agency (EPA). 1985a. Proposed guidelines for the health risk assessment of chemical mixtures. Fed. Reg. 50:1170–1176.
Environmental Protection Agency (EPA). 1985b. Chemical Emergency Preparedness Program, Interim Guidance, Washington, D.C.
Environmental Protection Agency (EPA). 1986a. Guidelines for carcinogen risk assessment, Fed. Reg.51:33992.
Environmental Protection Agency (EPA). 1986b. Guidelines for health assessment of suspect developmental toxicants. Fed. Reg. 51:34028.
Environmental Protection Agency (EPA). 1986c. Guidelines for mutagenicity risk assessment. Fed. Reg.51:34006.
Environmental Protection Agency (EPA). 1986d. Guidelines for estimating exposure. Fed. Reg. 51:34042.
Environmental Protection Agency (EPA). 1986e. Guidelines for the health risk assessment of chemical mixtures. Fed. Reg. 51:34014.
Environmental Protection Agency (EPA). 1991. Public meeting on EPA’s scientific assessment of dioxin. U.S. Environmental Protection Agency. Fed. Reg. 56:50903–50904.
Foster, S., and P. Chrostowski. 1987. Inhalation exposures to volatile organic contaminants in the shower. Presented at 80th annual meeting of the Air Pollution Control Association, New York, June 21.
HEAST. 1991. Health Effects Assessment Summary Tables. U.S. Environmental Protection Agency. Office of Research and Development, Washington, D.C.
Interagency Regulatory Liaison Group (IRLG). 1979. Scientific bases for identification of potential carcinogens and estimation of risks. J. Natl. Cancer Inst. 63:244–268.
IRIS. 1991. Integrated Risk Information System. U.S. Environmental Protection Agency. Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office, Cincinnati, Ohio.
Levine, T., A. Rispin, C.S. Scott, W. Marcus, C. Chen, and H. Libb. 1987. Special Report on Ingested Inorganic Arsenic: Skin Cancer; Nutritional Essentiality. Draft for U.S. Environmental Protection Agency Science Advisory Board Review.
Moolgavkar, S. H. 1986. Carcinogenesis modeling: From molecular biology to epidemiology. Ann. Rev. Pub. Health 7:151–169.
Moolgavkar, S.H., and A.G. Knudson. 1981. Mutation and cancer: A model for human carcinogenesis. J. Natl. Cancer Inst. 66:1037.
Moore, J.A. 1987. Recommended Agency Policy on the Carcinogenicity Risk Associated with the Ingestion of Inorganic Arsenic--Action Memorandum. U.S. Environmental Protection Agency. Office of Pesticides and Toxic Substances.
National Academy of Sciences (NAS). 1982. Risk and Decision Making: Perspectives and Research, National Research Council Committee on Risk and Decision Making, National Academy of Sciences Press, Washington, D.C.
National Academy of Sciences/National Research Council (NAS/NRC). 1983. Risk Assessment in the Federal Government: Managing the Process. Prepared by the Committee on the Institutional Means for Assessment of Risk to Public Health, Commission on Life Sciences (National Academy Press, Washington, D.C.).
National Academy of Sciences (NAS). 1986. Ecological Knowledge and Environmental Problem Solving: Concepts and Case Studies, National Research Council Committee on Risk and Decision Making, National Academy of Sciences Press, Washington, D.C.
Office of Science and Technology Policy (OSTP). 1984. Chemical carcinogens: Notice of review of the science and its associated principles. Fed. Reg 49:21594–21661.
Parsons, F., Wood, P.R., and DeMarco, J. 1984. Transformation of tetrachloroethene and trichloroethane in microcosms and groundwater. Res. Technol. P. 56.
Patrick, D., and Peters, W.D. 1985. Exposure assessment in setting air pollution regulations: ASARCO, Tacoma, a case study. Presented at the Society for Risk Analysis annual meeting. Washington, D.C.
Sawhney, B.L., Pignatello, J.J., and Steinberg, S.M. 1988. Determination of 1,2-dibromoethane (EDB) in field soils: Implications for volatile organic compounds. J. Environ. Qual. 17:149.
Sehmel, G.A., and Hodgson, W.H. 1979. A Model for Predicting Dry Deposition of Particles and Gases to Environmental Surfaces. Prepared for the U.S. Department of Energy by Pacific Northwest Laboratory. October. PNL-SA-6271-REV 1.
Thorslund, T. W. 1987. Quantitative Dose-Response Model for the Tumor Promoting Activity of TCDD. (Submitted to Environmental Protection Agency).
Thorslund, T. W., Brown, C. C., and Charnley, G. 1987a. The use of biologically motivated mathematical models to predict the actual cancer risk associated with environmental exposure to a carcinogen. J. Risk Anal. 7:109–119.
Thorslund, T. W., Charnley, G., Bayard, S., and Brown, R. 1987b. Quantitative Model for the Tumor Promoting Activity of 2,3,7,8-TCDD. (Presented at the Seventh International Symposium on Chlorinated Dioxins and Related Compounds, Las Vegas, Nevada, October 4–9, 1987.)
van den Berg, M., van Greevenbroek, M., Olie, K., Hatzinder, O. 1986. Bioavailability of PCDDs and PCDFs on fly ash after semi-chronic ingestion by rat. Chemosphere 15:509.
Voytek, P.E., and Thorslund, T.W. 1991. Benzene risk assessment: Status of quantifying the leukemogenic risk associated with the low-dose inhalation of benzene. Risk Anal. 11:355–357.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Anderson, E.L. (1992). Cancer Risk Assessments: An Overview. In: Zervos, C. (eds) Oncogene and Transgenics Correlates of Cancer Risk Assessments. NATO ASI Series, vol 232. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3056-5_1
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3056-5_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6333-0
Online ISBN: 978-1-4615-3056-5
eBook Packages: Springer Book Archive